Hospital-acquired pneumonia laboratory findings

Pneumonia Main Page
Hospital-acquired pneumonia Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Hospital-Acquired Pneumonia from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
Diagnostic Algorithm
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
Other Imaging Findings
Treatment
Medical Therapy
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hospital-acquired pneumonia laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hospital-acquired pneumonia laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hospital-acquired pneumonia laboratory findings
CDC onHospital-acquired pneumonia laboratory findings
Hospital-acquired pneumonia laboratory findings in the news
Blogs on Hospital-acquired pneumonia laboratory findings
Directions to Hospitals Treating Hospital-acquired pneumonia
Risk calculators and risk factors for Hospital-acquired pneumonia laboratory findings

Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D. ; Philip Marcus, M.D., M.P.H.

Overview

Current guidelines recommend a combination of chest Xray,laboratory data as well as clinical judgment in diagnosis and management of community acquired pneumonia.

Laboratory Findings

Basic Blood Works

• Complete blood count (leucocytosis). In some people with compromised immunity, the white blood cell count may appear deceptively normal.
• Basic metabolic panel
  • Used to evaluate kidney function when prescribing certain antibiotics
  • Hyponatremia in pneumonia is thought to be due to excess anti-diuretic hormone produced when the lungs are diseased (SIADH)

Culture

Sputum Culture

• Sputum gram stain and culture have poor yield. Sputum culture provides diagnostics information in roughly 1 in 5 patients only.
• Sputum cultures generally take at least two to three days, so they are mainly used to confirm that the infection is sensitive to an antibiotic that has already been started.
• A good sputum sample contains small number of squamous epithelial cells and a large number of PMNs.

Blood Culture

• Blood cultures are not recommended for the outpatient management of CAP due to the low yield of pathogens.
• A blood sample may similarly be cultured to look for infection in the blood (blood culture). Any bacteria identified are then tested to see which antibiotics will be most effective.

Serology

• Specific blood serology tests for other bacteria (Mycoplasma, Legionella and Chlamydophila) can be done in conditions with strong suspicion of the causative organisms.

Oxygen Monitoring

• Pulse oximeter
• Arterial blood gas

Respiratory Samples for VAP

Bronchial Samples Over Non-bronchial Sample

Advantages	Disadvantages
Helps in accurate diagnosis and selection of narrow antibiotic regimen. Thus, decreases incidence of antibiotic resistance. Quantitative cultures from nonbronchoscopic specimens have a lower specificity than quantitative cultures derived from bronchoscopic specimens.	Obtaining bronchial sample is more invasive and risk of injuries are more compared to the non-invasive methods.

Bronchial Samples

• Broncho-alveolar lavage
• Protected specimen brush

Non-Bronchial Sample

• Tracheo-bronchial aspiration
• Mini-bronchoalveloar lavage

Quantitative Culture

• Tracheobronchial aspiration - > 1 million cfu / mL is
• Bronchoalveolar lavage - > 10,000 cfu / mL
• PSB (protected brush sampling) - > 1,000 cfu / mL

Semi-quantitative Culture

• Report bacterial growth as heavy, moderate, light, or no growth.
• A moderate to heavy growth is suggestive of ventilator associated pneumonia.
• More false positive results compared to quantitative cultures.

Special Tests

• In more severe cases, (bronchoscopy) can be used collect fluid for culture.
• Special tests can be performed if an uncommon microorganism is suspected (such as testing the urine for Legionella antigen when Legionnaires' disease is a concern).
• HIV testing should be performed on all patients presenting with CAP (ages 13 to 75) in a medical setting.
• Respiratory secretions can also be tested for the presence of viruses such as influenza, respiratory syncytial virus, and adenovirus.

Major Points and Recommendations for Laboratory Tests in Adults with Hospital-Acquired, Ventilator-Associated, and Healthcare-Associated Pneumonia

“

Arterial oxygenation saturation should be measured in all patients to determine the need for supplemental oxygen. Arterial blood gas should be determined if concern exists regarding either metabolic or respiratory acidosis, and this test generally is needed to manage patients who require mechanical ventilation. These results, along with other laboratory studies (complete blood count, serum electrolytes, renal and liver function), can point to the presence of multiple organ dysfunction and thus help define the severity of illness (Level II). All patients with suspected VAP should have blood cultures collected, recognizing that a positive result can indicate the presence of either pneumonia or extrapulmonary infection (Level II). A diagnostic thoracentesis to rule out a complicating empyema or parapneumonic effusion should be performed if the patient has a large pleural effusion or if the patient with a pleural effusion appears toxic (Level III). Samples of lower respiratory tract secretions should be obtained from all patients with suspected HAP, and should be collected before antibiotic changes. Samples can include an endotracheal aspirate, bronchoalveolar lavage sample, or protected specimen brush sample (Level II)

”

For Level of evidence and classes click here.